ARHGAP35
Rho GTPase-activating protein 35
Also known as: GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP, RHG35_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRY4
- Gene
- ARHGAP35
- Ensembl
- ENSG00000160007
- Chromosome
- 19
- Canonical length
- 1499 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nuclear bodies,Microtubules,Aggresome
OverviewNCBI Gene
The human glucocorticoid receptor DNA binding factor, which associates with the promoter region of the glucocorticoid receptor gene (hGR gene), is a repressor of glucocorticoid receptor transcription. The amino acid sequence deduced from the cDNA sequences show the presence of three sequence motifs characteristic of a zinc finger and one motif suggestive of a leucine zipper in which 1 cysteine is found instead of all leucines. The GRLF1 enhances the homologous down-regulation of wild-type hGR gene expression. Biochemical analysis suggests that GRLF1 interaction is sequence specific and that transcriptional efficacy of GRLF1 is regulated through its interaction with specific sequence motif. The level of expression is regulated by glucocorticoids. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1499 residues, UniProt reviewed canonical sequence.
>Q9NRY4|ARHGAP35
1 MMMARKQDVR IPTYNISVVG LSGTEKEKGQ CGIGKSCLCN RFVRPSADEF HLDHTSVLST
61 SDFGGRVVNN DHFLYWGEVS RSLEDCVECK MHIVEQTEFI DDQTFQPHRS TALQPYIKRA
121 AATKLASAEK LMYFCTDQLG LEQDFEQKQM PDGKLLVDGF LLGIDVSRGM NRNFDDQLKF
181 VSNLYNQLAK TKKPIVVVLT KCDEGVERYI RDAHTFALSK KNLQVVETSA RSNVNVDLAF
241 STLVQLIDKS RGKTKIIPYF EALKQQSQQI ATAKDKYEWL VSRIVKNHNE NWLSVSRKMQ
301 ASPEYQDYVY LEGTQKAKKL FLQHIHRLKH EHIERRRKLY LAALPLAFEA LIPNLDEIDH
361 LSCIKAKKLL ETKPEFLKWF VVLEETPWDA TSHIDNMENE RIPFDLMDTV PAEQLYEAHL
421 EKLRNERKRV EMRRAFKENL ETSPFITPGK PWEEARSFIM NEDFYQWLEE SVYMDIYGKH
481 QKQIIDKAKE EFQELLLEYS ELFYELELDA KPSKEKMGVI QDVLGEEQRF KALQKLQAER
541 DALILKHIHF VYHPTKETCP SCPACVDAKI EHLISSRFIR PSDRNQKNSL SDPNIDRINL
601 VILGKDGLAR ELANEIRALC TNDDKYVIDG KMYELSLRPI EGNVRLPVNS FQTPTFQPHG
661 CLCLYNSKES LSYVVESIEK SRESTLGRRD NHLVHLPLTL ILVNKRGDTS GETLHSLIQQ
721 GQQIASKLQC VFLDPASAGI GYGRNINEKQ ISQVLKGLLD SKRNLNLVSS TASIKDLADV
781 DLRIVMCLMC GDPFSADDIL FPVLQSQTCK SSHCGSNNSV LLELPIGLHK KRIELSVLSY
841 HSSFSIRKSR LVHGYIVFYS AKRKASLAML RAFLCEVQDI IPIQLVALTD GAVDVLDNDL
901 SREQLTEGEE IAQEIDGRFT SIPCSQPQHK LEIFHPFFKD VVEKKNIIEA THMYDNAAEA
961 CSTTEEVFNS PRAGSPLCNS NLQDSEEDIE PSYSLFREDT SLPSLSKDHS KLSMELEGND
1021 GLSFIMSNFE SKLNNKVPPP VKPKPPVHFE ITKGDLSYLD QGHRDGQRKS VSSSPWLPQD
1081 GFDPSDYAEP MDAVVKPRNE EENIYSVPHD STQGKIITIR NINKAQSNGS GNGSDSEMDT
1141 SSLERGRKVS IVSKPVLYRT RCTRLGRFAS YRTSFSVGSD DELGPIRKKE EDQASQGYKG
1201 DNAVIPYETD EDPRRRNILR SLRRNTKKPK PKPRPSITKA TWESNYFGVP LTTVVTPEKP
1261 IPIFIERCIE YIEATGLSTE GIYRVSGNKS EMESLQRQFD QDHNLDLAEK DFTVNTVAGA
1321 MKSFFSELPD PLVPYNMQID LVEAHKINDR EQKLHALKEV LKKFPKENHE VFKYVISHLN
1381 KVSHNNKVNL MTSENLSICF WPTLMRPDFS TMDALTATRT YQTIIELFIQ QCPFFFYNRP
1441 ITEPPGARPS SPSAVASTVP FLTSTPVTSQ PSPPQSPPPT PQSPMQPLLP SQLQAEHTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARHGAP35 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- testis: 33 nTPM
- parathyroid gland: 27 nTPM
- skeletal muscle: 26 nTPM
- cerebral cortex: 25 nTPM
- heart muscle: 22 nTPM
- amygdala: 22 nTPM
Single-cell type
- late spermatids: 1,190 nCPM
- oligodendrocytes: 236 nCPM
- microglia: 214 nCPM
- choroid plexus epithelial cells: 212 nCPM
- early spermatids: 206 nCPM
- hepatocytes: 179 nCPM
Immune cell
- gdT-cell: 0.6 nTPM
- MAIT T-cell: 0.6 nTPM
- memory CD8 T-cell: 0.6 nTPM
- memory CD4 T-cell: 0.5 nTPM
- basophil: 0.3 nTPM
- plasmacytoid DC: 0.3 nTPM
Brain region
- hippocampal formation: 104 nTPM
- amygdala: 102 nTPM
- pons: 101 nTPM
- midbrain: 97 nTPM
- hypothalamus: 97 nTPM
- cerebral cortex: 94 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ARHGAP35.
Disease | GeneticClinVar
20 pathogenic / likely-pathogenic of 173 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.06
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.16
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon guidance
- axonal fasciculation
- camera-type eye development
- cell migration
- central nervous system neuron axonogenesis
- establishment or maintenance of actin cytoskeleton polarity
- forebrain development
- mammary gland development
- negative regulation of Rho protein signal transduction
- negative regulation of vascular permeability
- neural tube closure
- neuron projection guidance
- positive regulation of cilium assembly
- positive regulation of neuron projection development
- regulation of actin cytoskeleton organization
- regulation of actin polymerization or depolymerization
- regulation of axonogenesis
- regulation of cell shape
- regulation of cell size
- regulation of small GTPase mediated signal transduction
- Rho protein signal transduction
- wound healing, spreading of cells
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Rho GTPase-activating protein domain
- Small GTPase
- FF domain
- Rho GTPase activation protein
- P-loop containing nucleoside triphosphate hydrolase
- Rho GTPase-activating protein, FF domain
- FF domain superfamily
- Rho GTPase-activating protein, pG2 domain
- Rho GTPase-activating protein, pG1 domain
- Rho GTPase-activating protein, pG1 and pG2 domain
- Rho GTPase-activating domain-containing protein
- Rho GTPase-activating protein 35-like, FF domain
- Ras family
- RhoGAP domain
- p190-A and -B Rho GAPs FF domain
- p190RhoGAP, pG1 and pG2 domains
- Rho GTPase-activating protein 35-like, FF domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARHGAP35 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARHGAP35 as an antibody target. Whether an autoantibody or antibody against ARHGAP35 could matter depends on whether native ARHGAP35 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARHGAP35 is annotated at the cell surface, where native ARHGAP35 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ARHGAP35 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...